Insight

Praveen Kumar Marimuthu: Key Highlights from ASCO 2025 Day 1

Praveen Kumar Marimuthu/X

May 31, 2025, 17:47

Praveen Kumar Marimuthu: Key Highlights from ASCO 2025 Day 1

Praveen Kumar Marimuthu, Assistant Professor of Medical Oncology at Christian Medical College and Hospital, shared a post on X:

“Key highlights from ASCO 25 Day 1 featuring takeaways on

mCRC : BREAKWATER, Checkmate 8HW, ANCHOR

Early CRC : Role of ctDNA

Breast : TDxD rechallenge

Supportive Care: Financial toxicity mitigation”

Praveen Kumar Marimuthu

More posts featuring ASCO 2025 on OncoDaily.

ASC0 25 ASCO ASCO 2025 Breast Cancer cancer Christian Medical College and Hospital CRC mCRC OncoDaily Oncology Praveen Kumar Marimuthu

FDA has Granted Full Market Approval for Papzimeos - NIH

Kirsty Duncan։ Thirty-two Months Into Fighting Cancer...

World’s Nicest Judge Frank Caprio Dies at 88 After Brave Battle with Pancreatic Cancer

Weight Loss Trial Reports Success for Breast Cancer Patients at One Year Mark

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

Youtube

Health Policy

Aug 22, 2025, 03:03

Guiding Families Through Childhood Cancer - The Dorcas Cancer Foundation

Voices

Aug 22, 2025, 02:57

Khalid El Bairi: How to Critically Appraise Randomized Controlled Trials

Career Updates

Aug 22, 2025, 02:54

Ajlan Al Zaki: New Beginnings at Cleveland Clinic Abu Dhabi

Voices

Aug 22, 2025, 02:51

Victoria Wolodzko Smart: Patient Navigation Summit 2025 - The Many Faces of Navigation

Voices

Aug 22, 2025, 02:49

Zainab Shinkafi-Bagudu: From Grants to Growth - Empowering Nigerian Women

Voices

Aug 21, 2025, 23:33

Ohio State Launches Groundbreaking First-in-Human Cancer Drug Trial

Societies

Aug 21, 2025, 23:08

Empowering Cancer Survivors Through the Believe In You Program - Sylvester Comprehensive Cancer Center

Insight

Aug 21, 2025, 20:26

Kevin Harrington Looks Forward to CONCORDE Study Results on DNA Damage Inhibitors and Radiotherapy

Voices

Aug 21, 2025, 20:00

Raymond Mailhot: Advancing Hodgkin Lymphoma Survivor Study with NCI Funding

Voices

Aug 21, 2025, 19:28

Parvati Tiwari: Advocates Express Alarm Over NCI’s Decision to End PBTC Funding for Pediatric Brain Tumor Trials

Insight

Aug 21, 2025, 19:11

Maria Tolia: Exploring Regional Nodal Irradiation in Node-Positive Breast Cancer

Voices

Aug 21, 2025, 18:25

Strengthening Academic Writing in Oncology Nursing - European Oncology Nursing Society